Search

everythinglearnresearchcommunity

for

Search:↓

IL-17 inhibitors are more effective than methotrexate in preventing psoriatic arthritis in psoriasis patients.

High-dose mizoribine effectively controls symptoms in adolescents with lupus while reducing steroid use, with manageable side effects.

PLA2R1 overexpression harms kidney cells by stopping their growth cycle.

Deucravacitinib improves symptoms and reduces inflammation in Lichen Planopilaris.

Triple therapy with clobetasol, hydroxychloroquine, and N-acetylcysteine is recommended for better outcomes in treating lichen planopilaris.

Antimalarial agents are effective for LPP, and intralesional steroids are effective for FFA.

The PML protein helps prevent skin cancer in mice.

Oral JAK inhibitors improved alopecia areata by modulating immune responses and boosting hair growth.

Different sPLA2 enzymes affect immunity, skin and hair health, reproduction, and may be potential targets for therapy.

PRMT5 inhibitors effectively fight adenoid cystic carcinoma in salivary glands.

Enhanced stem cells from the placenta can reduce fat cell formation in eye disease.

Combining MMP-9 and JAK inhibitors can effectively prevent skin depigmentation in vitiligo.

PLAU and SerpinB2 affect cell death differently in various forms of leprosy and could be targets for new treatments.

Inhibiting PLA2 enzymes may help treat inflammatory skin diseases like psoriasis and dermatitis.

Mycophenolate mofetil may improve lupus nephritis remission more than cyclophosphamide but with uncertain safety.

Janus kinase inhibitors are promising drugs for treating autoimmune and inflammatory diseases.

Intralesional triamcinolone acetonide can effectively limit the progression of GLPLS.

Letrozole may help prevent seizures by reducing certain hormone levels.

Baricitinib may effectively treat oral lichen planus.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

Tildrakizumab significantly improved recalcitrant lichen planopilaris and frontal fibrosing alopecia.

Blocking JAK3 signaling can reverse hair loss from alopecia areata.

Blocking JAK1 or JAK3 helps reverse hair loss in a mouse model of alopecia areata.

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.

Pembrolizumab can cause serious liver issues, requiring close monitoring and early treatment.

JAK inhibitors are safe and effective for treating moderate-to-severe alopecia areata.

Careful monitoring is crucial to prevent JC virus reactivation in lupus patients treated with rituximab.

JAK inhibitors show promise in treating difficult skin diseases.

JAK inhibitors may become the first approved treatment for alopecia areata if they are proven safe and effective.

Inhibiting plant sterols reduces grapevine pathogen reproduction.